Is Climbazole safe in cosmetics?
Climbazole has a safety rating of "GOOD" in our database. EU status: restricted. US status: permitted. 10 toxicological study endpoint(s) are available in our database.
Also known as: 5-23-04-00209, Baypival, BRN 0618020, 1-(p-Chlorophenoxy)-3,3-dimethyl-1-(1-imidazolyl)-2-butanone, 1-(4-Chlorophenoxy)-1-(imidazol-1-yl)-3,3-dimethylbutanone (+4 more)
INCI: CLIMBAZOLE
Climbazole (CAS 38083-17-9) is a cosmetic active ingredient functioning as Antifungal; anti-dandruff active; preservative. NOAEL 5 mg/kg bw/day (PDF-verified against ToxValDB ECHA IUCLID); EU Regulation 1223/2009 status: restricted, max 2.0% rinse-off (anti-dandruff) / 0.5% rinse-off (preservative) / 0.2% leave-on (preservative). Industrial safety data is also available in the chemical safety database. Same-CAS public records also appear in industrial chemical safety and pharmaceutical data.
View industrial chemical safety profile for CAS 38083-17-9 →
For full compliance data across multiple jurisdictions, use the Substance Compliance tool.
Margin of Safety, dermal absorption, and sensitization profile summaries for Climbazole.
Calculate MoS for your specific formulation with the MoS Calculator.
10 study endpoints found for Climbazole. NOAEL (No Observed Adverse Effect Level) values are used to calculate the Margin of Safety per SCCS methodology.
| Endpoint | Value | Route | Species | Study Type | Source |
|---|---|---|---|---|---|
| NOAEL | =5 mg/kg bw/day | oral | rat | NOAEL study | SCCS Opinion |
| NOAEL | =5 mg/kg/day | oral | rat | developmental toxicity | SCCS Opinion |
| NOAEL | =5 mg/kg bw/day | oral | rat | repeated dose toxicity | SCCS Opinion |
| NOAEL | =5 mg/kg bw/day | oral | rat | NOAEL study | SCCS Opinion |
| NOAEL | =5 mg/kg/day | oral | rat | developmental toxicity | SCCS Opinion |
| NOAEL | =5 mg/kg bw/day | oral | rat | NOAEL study | SCCS Opinion |
| NOAEL | =5 mg/kg/day | oral | rat | developmental toxicity | SCCS Opinion |
| NOAEL | =5 mg/kg bw/day | oral | rat | repeated dose toxicity | SCCS Opinion |
| NOAEL | =5 mg/kg bw/day | oral | rat | repeated dose toxicity | SCCS Opinion |
| NOAEL | =5 mg/kg bw/day | oral | rat | NOAEL study | SCCS Opinion |
Pre-calculated NOAEL → SED → MoS audit trail for Climbazole across SCCS product categories, with measured dermal absorption where available.
NOAEL/LOAEL values cited in official SCCS opinions for Climbazole.
| NOAEL | LOAEL | Route | Species | Study | DA% (SCCS) | Opinion |
|---|---|---|---|---|---|---|
| 20 mg/kg/day | 200 mg/kg/day | Oral | Rat | Subchronic (90-day) (90 days) | 100 | SCCS/1506/13 (2013) |
Contact sensitization data for Climbazole based on clinical patch test studies and IFRA standards.
Source: ESSCA; IVDK; NACDG
European Chemicals Agency REACH dossier and Substances of Very High Concern listing.
European Commission CosIng database Annex references per Regulation (EC) No 1223/2009.
Additional regulatory detail beyond the 7-jurisdiction summary: Saudi SFDA, Korea MFDS, ASEAN ACD, Japan/Korea, Brazil/India, and cross-jurisdictional restriction entries.
| Jurisdiction | Status | Max % | Product Type |
|---|---|---|---|
| CN | permitted_preservative | 0.5 | Rinse-off hair products only |
| IN | permitted_preservative | 0.5 | all cosmetics |
| BR | restricted | 2 | Anti-dandruff rinse-off shampoos only; RDC 806/2023 restriction |
| BR | permitted_preservative | 0.5 (shampoo) / 0.2 (face/hair/foot) | a) Rinse-off shampoos: 0.5%; b) Face creams, hair lotions, foot care: 0.2%; As preservative (*) symbol |
| ASEAN | permitted_preservative | 0.5% | All products |
| TH | restricted | 0.5% (per ACD Annex VI) | All products containing Climbazole |
Cross-database dermal penetration: EPA Dryad physics-based, Roberts Mendeley permeation, and SCCS-aggregated measured values.
| Type | DA % | Method | Skin Model | SCCS Ref |
|---|---|---|---|---|
| measured_sccs_opinion | 100.0% | - | - | SCCS/1506/13 |
| measured_sccs_opinion | 0.15% | - | - | SCCP/1204/08 |
| measured_sccs_opinion | 0.15% | - | - | SCCS/1506/13 |
Preliminary editorial summary for Climbazole — not a computed safety verdict. See the sourced toxicological data above.
Public NOAEL study rows linked to Climbazole by CAS number or substance name.
Units vary across source rows: mg/kg bw/day, mg/kg/day, mg/kg
| Absorption % | Method | Vehicle |
|---|---|---|
| 100.0% | SCCS opinion extraction | - |
| 0.15% | SCCS opinion extraction | - |
| 0.15% | SCCS opinion extraction | - |
Same-CAS public records found in pharmaceutical data.
Same-CAS rows from the pharmaceutical spoke database.
Climbazole has a safety rating of "GOOD" in our database. EU status: restricted. US status: permitted. 10 toxicological study endpoint(s) are available in our database.
Climbazole EU regulatory status: restricted. Maximum allowed concentration: 2.0% rinse-off (anti-dandruff) / 0.5% rinse-off (preservative) / 0.2% leave-on (preservative). This is based on EU Regulation 1223/2009 and its amendments.
Climbazole functions as: Antifungal; anti-dandruff active; preservative. It is classified as a Active Ingredient in our database. CAS number: 38083-17-9.
The NOAEL (No Observed Adverse Effect Level) for Climbazole is =5 mg/kg bw/day based on a NOAEL study study via oral route in rat. A total of 10 study endpoints are available. Source: SCCS Opinion.
Climbazole also appears in industrial chemical safety and pharmaceutical data. The cross-vertical cards on this page render same-CAS public rows from the matched databases.
Check Climbazole compliance across multiple jurisdictions:
Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.
Try Piro Free →Paste any INCI list into the Decoder for instant safety analysis, or calculate the Margin of Safety for Climbazole in your formulation.